Sheng Kang Selected Research

Acute Coronary Syndrome

8/2013

Effects of aggressive statin therapy on patients with coronary saphenous vein bypass grafts: a systematic review and meta-analysis of randomized, controlled trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sheng Kang Research Topics

Disease

11	Myocardial Infarction 01/2021 - 09/2004
6	Cardiovascular Diseases (Cardiovascular Disease) 02/2021 - 07/2006
6	Heart Failure 12/2020 - 05/2006
5	Death (Near-Death Experience) 08/2013 - 11/2007
4	Coronary Artery Disease (Coronary Atherosclerosis) 02/2021 - 12/2004
4	Stroke (Strokes) 08/2008 - 09/2004
3	Neoplasms (Cancer) 01/2022 - 06/2006
3	Ischemia 01/2015 - 01/2007
3	Infarction (Infarctions) 11/2011 - 11/2007
3	Thrombosis (Thrombus) 11/2007 - 07/2006
2	Osteoporosis 01/2022 - 01/2022
2	Insulin Resistance 01/2022 - 01/2022
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 10/2009
2	Fibrosis (Cirrhosis) 12/2020 - 12/2020
2	Hypertrophy 12/2020 - 12/2020
2	Systolic Heart Failure 01/2017 - 02/2015
2	Reperfusion Injury 01/2015 - 01/2007
2	Hypertension (High Blood Pressure) 10/2009 - 02/2004
2	Cardiac Arrhythmias (Arrythmia) 08/2008 - 11/2007
1	Bone Resorption 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Hemorrhage 10/2021
1	ST Elevation Myocardial Infarction 10/2021
1	Atrial Fibrillation 01/2021
1	Vascular Calcification 04/2020
1	Atherosclerosis 04/2020
1	Alzheimer Disease (Alzheimer's Disease) 04/2020
1	Carcinogenesis 04/2020
1	Ventricular Remodeling 01/2017
1	Necrosis 01/2015
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2015
1	Muscular Diseases (Myopathy) 08/2013
1	Acute Coronary Syndrome 08/2013
1	Infections 08/2013
1	No-Reflow Phenomenon 11/2011
1	Arteriosclerosis 11/2010
1	Coronary Occlusion 05/2009
1	Hypercholesterolemia 08/2008
1	Diabetes Mellitus 08/2008
1	AIDS-Related Complex (ARC) 11/2007

Drug/Important Bio-Agent (IBA)

5	omega-Chloroacetophenone (Mace)IBA 10/2021 - 07/2006
3	Blood Glucose (Blood Sugar)IBA 01/2022 - 04/2020
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2013 - 12/2004
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 09/2004
2	Insulin-Like PeptidesIBA 01/2022 - 01/2022
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2022
2	CholesterolIBA 01/2022 - 09/2004
2	Circular RNAIBA 12/2020 - 12/2020
2	C-Reactive ProteinIBA 01/2017 - 10/2009
2	tongxinluoIBA 01/2015 - 05/2009
2	Antihypertensive Agents (Antihypertensives)IBA 09/2004 - 02/2004
1	Endothelins (Endothelin)IBA 01/2022
1	glimepiride (Amarel)FDA LinkGeneric 01/2022
1	Tartrate-Resistant Acid PhosphataseIBA 01/2022
1	EnzymesIBA 01/2022
1	GlucosidasesIBA 01/2022
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022
1	Insulin (Novolin)FDA Link 01/2022
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2022
1	LipidsIBA 01/2022
1	Malondialdehyde (Propanedial)IBA 01/2022
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Glycoside Hydrolase InhibitorsIBA 01/2022
1	TicagrelorIBA 10/2021
1	vasodilator-stimulated phosphoproteinIBA 10/2021
1	MicroRNAs (MicroRNA)IBA 02/2021
1	IronIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Biological ProductsIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 04/2020
1	LDL Receptors (LDL Receptor)IBA 04/2020
1	Pharmaceutical PreparationsIBA 04/2020
1	IvabradineIBA 10/2017
1	CytokinesIBA 01/2017
1	Environmental Pollutants (Pollutants, Environmental)IBA 02/2016
1	Particulate MatterIBA 02/2016
1	Phosphotransferases (Kinase)IBA 02/2015
1	GTP-Binding Proteins (G-Protein)IBA 02/2015
1	Simvastatin (Zocor)FDA LinkGeneric 08/2013
1	Transaminases (Aminotransferases)IBA 08/2013
1	Atorvastatin (Lipitor)FDA Link 08/2013
1	Pravastatin (Pravachol)FDA LinkGeneric 08/2013
1	oxidized low density lipoproteinIBA 08/2013
1	Coloring Agents (Dyes)IBA 11/2011
1	Connexin 43 (Connexin43)IBA 11/2011
1	AlbuminsIBA 10/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2009
1	human esRAGE proteinIBA 10/2009
1	Lipoprotein(a)IBA 10/2009
1	cadherin 5IBA 06/2009
1	salicylhydroxamic acid (SHAM)IBA 05/2009
1	Sirolimus (Rapamycin)FDA Link 11/2007
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2007

Therapy/Procedure

9	Therapeutics 10/2021 - 02/2004
4	Stents 08/2008 - 07/2006
2	Patient Readmission 08/2008 - 11/2007
1	Radiofrequency Ablation 01/2021
1	Ligation 11/2011